Fatal Borealpox in an Immunosuppressed Patient Treated With Antivirals and Vaccinia Immunoglobulin—Alaska, 2023

This report demonstrates that BRPV can cause overwhelming disseminated infection in certain immunocompromised patients. Based on the patient's initial response, early BRPV identification and antiviral therapies might have been beneficial. These therapies, in combination with optimized immune function, should be considered for patients at risk for manifestations of BRPV.

Authors

Institutions

Publication Details

Journal
Clinical Infectious Diseases
Published
2024-11-05
DOI
https://doi.org/10.1093/cid/ciae536
Citations
5
Primary Topic
Poxvirus research and outbreaks
Type
article
Field-Weighted Citation Impact
1.47
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fatal Borealpox in an Immunosuppressed Patient Treated With Antivirals and Vaccinia Immunoglobulin—Alaska, 2023

Julia H. Rogers, Li Yu, Alexandra Tuttle, Julian A. Villalba et al.
5 citations
Clinical Infectious Diseases
Poxvirus research and outbreaks
1.47
article

Fatal Borealpox in an Immunosuppressed Patient Treated With Antivirals and Vaccinia Immunoglobulin—Alaska, 2023

Julia H. Rogers, Li Yu, Alexandra Tuttle, Julian A. Villalba, Joseph B McLaughlin, Agam K. Rao, Andrea M. McCollum, John Laurance, Louisa J. Castrodale, Benjamin Westley, Sarah Y. Park, Sivan Bercovici, Kimberly Wilkins, Shivkumar Venkatasubrahmanyam, Jayme Parker, Sarah Reagan-Steiner, Jeffrey B. Doty, Michael B. Townsend, Christina L. Hutson, Panayampalli S. Satheshkumar, K. David Newell, Jiusheng Deng, Nicholas Noll, William Carson, Whitni Davidson, Crystal M. Gigante, Julu Bhatnagar, Lisa Smith, Thomas Mego
article en
5 citations

Abstract

This report demonstrates that BRPV can cause overwhelming disseminated infection in certain immunocompromised patients. Based on the patient's initial response, early BRPV identification and antiviral therapies might have been beneficial. These therapies, in combination with optimized immune function, should be considered for patients at risk for manifestations of BRPV.

Clinical Infectious DiseasesVol. 80(5)
Centers for Disease Control and Prevention (US), Providence Alaska Medical Center (US), Alaska Department of Health and Social Services (US), Centers for Disease Control and Prevention (UG), Epidemic Intelligence Service (US)
Zero hunger
Openalex Percentile: Top 18%
Poxvirus research and outbreaks
1.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.